Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Current Assets (2020 - 2025)

Historic Current Assets for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to $124.6 million.

  • Maxcyte's Current Assets fell 2791.29% to $124.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.6 million, marking a year-over-year decrease of 2791.29%. This contributed to the annual value of $171.7 million for FY2024, which is 973.22% down from last year.
  • Latest data reveals that Maxcyte reported Current Assets of $124.6 million as of Q3 2025, which was down 2791.29% from $143.2 million recorded in Q2 2025.
  • In the past 5 years, Maxcyte's Current Assets ranged from a high of $270.4 million in Q4 2021 and a low of $84.6 million during Q2 2021
  • For the 5-year period, Maxcyte's Current Assets averaged around $203.5 million, with its median value being $202.3 million (2023).
  • In the last 5 years, Maxcyte's Current Assets surged by 49759.66% in 2021 and then crashed by 2791.29% in 2025.
  • Quarter analysis of 5 years shows Maxcyte's Current Assets stood at $270.4 million in 2021, then decreased by 6.72% to $252.3 million in 2022, then decreased by 24.61% to $190.2 million in 2023, then dropped by 9.73% to $171.7 million in 2024, then fell by 27.4% to $124.6 million in 2025.
  • Its Current Assets was $124.6 million in Q3 2025, compared to $143.2 million in Q2 2025 and $155.7 million in Q1 2025.